Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,729 | 11 | 55.6% |
| Food and Beverage | $5,236 | 110 | 29.9% |
| Travel and Lodging | $1,919 | 8 | 11.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $430.00 | 1 | 2.5% |
| Education | $181.94 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $6,177 | 26 | $0 (2024) |
| Adaptive Biotechnologies Corporation | $5,383 | 26 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $2,429 | 13 | $0 (2023) |
| Janssen Biotech, Inc. | $717.37 | 11 | $0 (2024) |
| TG THERAPEUTICS, INC. | $630.00 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $543.99 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $506.54 | 12 | $0 (2024) |
| BeiGene USA, Inc. | $382.20 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $126.86 | 1 | $0 (2023) |
| Genentech, Inc. | $115.77 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,492 | 43 | Adaptive Biotechnologies Corporation ($4,356) |
| 2023 | $4,124 | 36 | ABBVIE INC. ($2,828) |
| 2022 | $3,795 | 36 | Pharmacyclics LLC, an AbbVie Company ($2,253) |
| 2021 | $4,085 | 17 | AbbVie Inc. ($2,837) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Oncology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $109.71 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Oncology | ||||||
| 11/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $43.95 | General |
| Category: Oncology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $112.03 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Infectious Diseases | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $8.31 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Consulting Fee | Cash or cash equivalent | $430.00 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Invivyd Inc | PEMGARDA (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Oncology | ||||||
| 09/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Oncology | ||||||
| 09/17/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $148.45 | General |
| Category: Oncology | ||||||
| 09/17/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $100.92 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/07/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $76.92 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Consulting Fee | Cash or cash equivalent | $2,257.50 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Consulting Fee | Cash or cash equivalent | $913.75 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $2.50 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 168 | 204 | $41,211 | $7,648 |
| 2022 | 3 | 82 | 92 | $15,482 | $4,030 |
| 2021 | 4 | 140 | 162 | $27,593 | $7,642 |
| 2020 | 2 | 114 | 152 | $20,386 | $4,188 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 87 | 114 | $19,476 | $5,097 | 26.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 49 | 57 | $6,890 | $1,289 | 18.7% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 17 | 17 | $12,895 | $880.43 | 6.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 15 | 16 | $1,950 | $382.08 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 55 | 63 | $10,444 | $2,839 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 12 | $3,023 | $760.96 | 25.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 16 | 17 | $2,015 | $429.67 | 21.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 70 | 85 | $13,440 | $3,982 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 40 | 42 | $10,236 | $2,801 | 27.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 18 | 18 | $2,014 | $429.93 | 21.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 12 | 17 | $1,903 | $429.93 | 22.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 64 | 90 | $13,656 | $3,188 | 23.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 50 | 62 | $6,730 | $1,001 | 14.9% |
About Jill Miller, PA-C
Jill Miller, PA-C is a Physician Assistant healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932370038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jill Miller, PA-C has received a total of $17,496 in payments from pharmaceutical and medical device companies, with $5,492 received in 2024. These payments were reported across 132 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($9,729).
As a Medicare-enrolled provider, Miller has provided services to 504 Medicare beneficiaries, totaling 610 services with total Medicare billing of $23,508. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Houston, TX
- Active Since 03/17/2008
- Last Updated 06/08/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1932370038
Products in Payments
- VENCLEXTA (Drug) $6,177
- clonoSEQ (Device) $5,383
- IMBRUVICA (Drug) $2,010
- Imbruvica (Drug) $1,122
- UKONIQ (Drug) $630.00
- CALQUENCE (Drug) $506.54
- BRUKINSA (Drug) $382.20
- REBLOZYL (Biological) $218.43
- Xospata (Drug) $167.51
- Lunsumio (Biological) $115.77
- JAKAFI (Drug) $113.25
- XOSPATA (Drug) $109.01
- Cresemba (Drug) $85.53
- SCEMBLIX (Drug) $83.76
- VONJO (Drug) $55.13
- Doptelet (Drug) $26.72
- BOSULIF (Drug) $23.69
- JAYPIRCA (Drug) $21.36
- PROMACTA (Drug) $18.99
- DOPTELET (Drug) $18.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Houston
Amanda Wilhite, Pa-C, PA-C
Physician Assistant — Payments: $136,303
Christina Yazdani, Pa-C, PA-C
Physician Assistant — Payments: $48,235
Jacqueline Weatherly, Pa-C, PA-C
Physician Assistant — Payments: $46,977
Julie Huynh-Lu, Pa-C, PA-C
Physician Assistant — Payments: $45,677
Virginia Schneider, Pa, PA
Physician Assistant — Payments: $43,222
Mr. James Smith, Pa-C, PA-C
Physician Assistant — Payments: $42,324